MICHELE CANFIELD: Open Payments
NPI 1033843172 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 58 payments from 12 companies in 2025. Trend: 2023 $2,709 · 2024 $967 · 2025 $1,642
Food & beverage: $1,554Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $454 |
| ABBVIE INC. | 10 | $262 |
| UCB, Inc. | 9 | $209 |
| SK Life Science, Inc. | 9 | $167 |
| Lilly USA, LLC | 4 | $162 |
| TG Therapeutics, Inc. | 1 | $124 |
| Eisai Inc. | 3 | $66 |
| Neurelis, Inc. | 3 | $53 |
| Biogen, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $42 |
Products named: QULIPTA, Briviact, BRIUMVI, KISUNLA, Leqembi, VALTOCO, NURTEC ODT, AMYVID.
Industry payments across VA — which companies pay providers there.
